Dextroamphetamine Sulfate Capsule, Extended Release
Product Images NDC 0115-9929

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Sulfate (NDC 0115-9929). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Amphetamine Sulfate (Dextroamphetamine Sulfate Er Capsules 1)

FDA Label Image

Ndc 0115-9927-10 (Dextroamphetamine Sulfate Er Capsules 2)

Ndc 0115-9927-10 (Dextroamphetamine Sulfate Er Capsules 2)
Each extended-release capsule of NOC 0115992710 contains Dextroamphetamine sulfate, with 11 mg of Dextroamphetamine sulfate for prompt release and 5 mg for gradual release over a prolonged period. The suggested dosage is mentioned in the accompanying prescribing information. Safety measures should be taken while dispensing the medication. It should be stored at a controlled room temperature between 20° to 25°C. It should be dispensed in a light-resistant container and only with the medication box provided. The product is distributed by Amneal Pharmaceuticals LLC, located in Bridgewater, NJ.*
FDA Label Image

Ndc 0115-9928-10 (Dextroamphetamine Sulfate Er Capsules 3)

Ndc 0115-9928-10 (Dextroamphetamine Sulfate Er Capsules 3)
This text is a prescription label for a medication called Dextroamphetamine Sulfate Extended-Release Capsules. Each capsule contains 10 mg of dextroamphetamine sulfate and is designed to release the initial dose promptly and the remaining medication gradually over a prolonged period. The dosage instructions are provided with the prescription. It is recommended to use safety closures and store the medication in a tight light-resistant container at a controlled room temperature between 20-25°C. The medication is manufactured by Gatalent Pharma Solutions and distributed by Amneal Pharmaceuticals LLC. The prescription was last revised in March 2019.*
FDA Label Image

Ndc 0115-9929-10 (Dextroamphetamine Sulfate Er Capsules 4)

Ndc 0115-9929-10 (Dextroamphetamine Sulfate Er Capsules 4)
This is the description for Dextroamphetamine Sulfate extended-release capsules. Each capsule contains 15mg of Dextroamphetamine Sulfate and is prepared in a way that the initial dose is released promptly while the remaining medication is released gradually over a prolonged period. The usual dosage and prescribing information should be referred to while using this product. Safety closures should be used while dispensing the product unless otherwise directed by the doctor. The capsules should be stored at a controlled room temperature between 20° to 25°C (68° to 77°F). The product should be dispensed in a tight, light-resistant container. The medication guide in the bottle should be followed as directed by Federal Law. The product is manufactured by Catalent Pharma Solutions in Winchester, KY 40391 and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ 08307.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.